Staar Surgical (STAA) Cash from Financing Activities (2010 - 2026)

Staar Surgical has reported Cash from Financing Activities for 17 years, with the latest figure at -$1.7 million in Q2 2026.

• For the quarter ending Q2 2026, Cash from Financing Activities fell 78.59% year-over-year to -$1.7 million; the trailing twelve-month figure through Apr 2026 stood at -$5.3 million (down 836.11% YoY), and the FY2026 full-year result was -$4.6 million, down 179.58% from the prior year.
• Cash from Financing Activities for Q2 2026 stood at -$1.7 million, down from -$50000.0 in the prior quarter.
• The five-year high for Cash from Financing Activities was $7.1 million in Q3 2023, with the low at -$4.5 million in Q2 2025.
• Historically, Cash from Financing Activities has averaged $893411.8 across 5 years, with a median of $367000.0 in 2023.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities soared 398.02% — and 2025, when it plunged 2885.28%.
• Staar Surgical's Cash from Financing Activities stood at $202000.0 in 2022, then surged by 81.68% to $367000.0 in 2023, then plunged by 129.97% to -$110000.0 in 2024, then surged by 993.64% to $983000.0 in 2025, then sank by 272.23% to -$1.7 million in 2026.
• The last three Cash from Financing Activities figures came in at -$1.7 million (Q2 2026), -$50000.0 (Q1 2026), and $983000.0 (Q3 2025), per Business Quant data.